论文部分内容阅读
目的:应用平阳霉素(PYM)与地塞米松(DXM)联合瘤腔内注射治疗婴幼儿颜面部血管瘤并观察其临床疗效。方法:54例婴幼儿颜面部血管瘤(61个瘤体)采用PYM、DXM联合行瘤腔内直接注射,1~2周重复,4~6次为一个疗程。结果:经6~24个月随访,治愈29例(53.70%),基本治愈20例(37.04%),有效5例(9.26%),治愈和基本治愈率90.74%。结论:PYM与DXM联合瘤腔内注射治疗婴幼儿颜面部血管瘤,具有疗程短、疗效好、副作用小、安全可靠等优点。
Objective: To apply the PYM combined with dexamethasone (DXM) intratumorally to treat infantile facial hemangioma and observe the clinical curative effect. Methods: Fifty-four infantile facial hemangiomas (61 tumors) were injected intra-articularly with PYM and DXM for 1 to 2 weeks. Four to six times a course of treatment. Results: After 6-24 months of follow-up, 29 cases (53.70%) were cured, 20 cases (37.04%) were basically cured, 5 cases (9.26%) were cured, and the cure and basic cure rate was 90.74%. Conclusion: PYM and DXM combined with intratumoral injection in the treatment of infantile facial and facial hemangiomas have the advantages of short course of treatment, good curative effect, little side effect, safety and reliability.